Coronavirus Covid-19 Information

NMIC Bulletin Vol. 25 No. 6 Pharmacotherapy of chronic heart failure

3 February, 2020

Pharmacotherapy of chronic heart failure

  • The management of heart failure should be a shared responsibility between patients, their carers and healthcare professionals
  • Pharmacological therapy has been shown to improve outcomes in patients with heart failure with reduced ejection fraction
  • Patients with heart failure with reduced ejection fraction should be treated with an angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker, beta blocker and mineralocorticoid receptor antagonist
  • Patients with heart failure require close monitoring